AzTrials
AzTrials

Multiple Sclerosis, Relapsing-RemittingNCT03497468

Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis

A study testing Combined exercise training and Task-oriented training in people with Multiple Sclerosis, Relapsing-Remitting, run by Bezmialem Vakif University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Multiple Sclerosis (MS) is inflammatory, demyelinating and autoimmune disease of the central nervous system. It is usually seen with relapses and genetic and environmental factors play a role in the etiology. Neurological symptoms seen in MS restrict the patient's daily activity and social role participation. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Multiple Sclerosis, Relapsing-Remitting
What is being tested?
Combined exercise training and Task-oriented training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
No sites listed yet
Study dates
Jan 2017to Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Multiple Sclerosis diagnosis
  • Expanded Disability Status Scale > 5,5
  • No cognitive problems
  • No relapses in the last 3 months
  • No other neurological or chronic disease

Who cannot join

  • Relapse during the intervention
  • Exercise intolerance

About this study

Multiple Sclerosis (MS) is inflammatory, demyelinating and autoimmune disease of the central nervous system. It is usually seen with relapses and genetic and environmental factors play a role in the etiology. Neurological symptoms seen in MS restrict the patient's daily activity and social role participation. Mobility problems and fatigue are the most important reasons of role limitations and decreased quality of life. The importance of exercise training in disease management has been emphasized in recent years. However, few studies have investigated the effects of task-oriented trainings on symptoms of the disease. The aim of this sudy is to investigate the effects of task-oriented training additional to combined exercise training on functional capacity, mobility, balance, fatigue and quality of life in patients with MS.

Being tested
Combined exercise training, Task-oriented training
Keywords
task-oriented training, exercise training, mobility, balance, fatigue, quality of life
Medical subject headings
Multiple Sclerosis, Relapsing-Remitting, Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined exercise trainingOther

    Aerobic training with cycle ergometer %60-80 of maximal Heart Rate, submaximal level, strengthening of the major muscles of upper and lower extremities

  • Task-oriented trainingOther

    Functional reaching, walking on different obstacles and floor,sitting and standing on different levels and surface,walking around obstacle, climbing stairs with different height and surface

Study groups in NCT03497468
Study groupRoleWhat they receive
Control groupActive comparatorPatients in this group will receive combined exercise training included aerobic and strengthening exercises, 3 times a week for 6 weeks. All exercise sessions will be performed under the supervision of a physiotherapist.
Receives: Other: Combined exercise training
Training groupExperimentalPatients in this group will receive task-oriented training additional to combined exercise training 3 times a week for 6 weeks. Task-oriented training included more functional daily life mobility activities like reaching, obstacle walking, stairs climbing. All exercise sessions will be performed under the supervision of a physiotherapist.
Receives: Other: Task-oriented training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional capacity

    Change from baseline functional capacity with six minute walking test

    Measured: 6 weeks

Secondary outcomes (8)
  1. dynamic gait skills

    Change from baseline functional mobility with dynamic gait index

    Measured: 6 weeks

  2. limitation of gait

    Change from baseline functional mobility with MS walking scale-12

    Measured: 6 weeks

  3. dynamic balance and fall risk

    Change from baseline functional mobility with timed up and go test

    Measured: 6 weeks

  4. sitatic balance

    Change from baseline balance with functional reach test

    Measured: 6 weeks

  5. dynamic balance

    Change from baseline balance with berg balance scale

    Measured: 6 weeks

  6. severity of fatigue

    Change from baseline fatigue with fatigue severity scale

    Measured: 6 weeks

  7. impact of fatigue

    Change from baseline fatigue with fatigue impact scale

    Measured: 6 weeks

  8. Quality of life

    Change from baseline quality of life with MS quality of life instrument-54

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2018
  2. Study startJan 2017
  3. Primary completion1 Dec 2017
  4. Study completionDec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03497468
Sponsor's protocol ID
kunal
Status last verified
Jun 2026
First submitted
3 Apr 2018
Last updated
1 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Combined exercise training and Task-oriented training in people with Multiple Sclerosis, Relapsing-Remitting, run by Bezmialem Vakif University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional capacity (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in